Clinical Trial

Improving the Quality of Cryopreserved Ovarian Tissue Reimplantation Using Platelet-enriched Autologous Plasma

Study acronym: TESOVA2022
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 15, 2024 (before its estimated December 29, 2024 completion). Its status may not reflect the trial's current state.
Summary
The study is aimed to evaluate the effects of intraovarian injection of autologous Platelet-enriched Autologous Plasma on the outcomes of orthotopic transplantation of cryopreserved ovarian tissue.
Trial Details
NCT Number NCT06261658
Lead Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions Cryopreservation, Ovary Injury, Infertility, Female, Menopause Ovarian Failure
Enrollment 45 participants
Start Date 2024-03-01
Primary Completion 2024-12-29 (estimated)
Study Completion 2033-12-29 (estimated)
Updated on ClinicalTrials.gov 2024-02-15